001     905420
005     20220131120330.0
024 7 _ |a 2128/30340
|2 Handle
037 _ _ |a FZJ-2022-00661
041 _ _ |a English
100 1 _ |a Hahn, Lisa
|0 P:(DE-Juel1)177012
|b 0
|e First author
|u fzj
111 2 _ |a Society of Biological Psychiatry 2021 Annual Meeting
|g SOBP
|c Online
|d 2021-04-28 - 2021-05-01
|w USA
245 _ _ |a Resting-state alterations in behavioral variant frontotemporal dementia are related to the distribution of monoamine and GABA neurotransmitter systems
260 _ _ |c 2021
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a CONFERENCE_POSTER
|2 ORCID
336 7 _ |a Output Types/Conference Poster
|2 DataCite
336 7 _ |a Poster
|b poster
|m poster
|0 PUB:(DE-HGF)24
|s 1642508102_6597
|2 PUB:(DE-HGF)
|x After Call
520 _ _ |a Background: Behavioral variant frontotemporal dementia (bvFTD) is characterized by changes in personality and behavior and by progressive structural and functional alterations in frontal and temporal regions. Only little is known about the relationship of these alterations with the underlying pathophysiology. Here, we explored if these alterations follow the distribution of specific neurotransmitter systems.Methods: We evaluated if resting state activity alterations in bvFTD are associated with the known in vivo distribution of specific neurotransmitter systems. For this, maps of fractional amplitude of low frequency fluctuations (fALFF) as derived from resting-state functional magnetic resonance imaging were computed for 52 bvFTD patients relative to 22 healthy controls (HC). We tested if these maps co-localize with the non-pathological distribution of specific neurotransmitter systems and their coding mRNA gene expression.Results: Compared to HC, patients displayed significantly reduced fALFF in fronto-temporal and fronto-parietal regions. These alterations significantly co-localized with the distribution of serotonin (5HT1b, 5HT2a), dopamine (D2), and gamma-aminobutyric acid type A (GABAa) receptors, and the noradrenaline transporter (NAT) (all p≤.001). Significant co-localization of fALFF alterations was also observed with mRNA expression of genes encoding the respective receptors and transporters.Conclusion: We showed that fALFF reduction in bvFTD co-localize with the spatial distribution of serotonergic, dopaminergic, GABAergic, and noradrenalinergic systems, and their coding mRNA gene expression. These findings provide novel insight into neuropathophysiological mechanisms underlying functional alterations in bvFTD.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
700 1 _ |a Eickhoff, Simon
|0 P:(DE-Juel1)131678
|b 1
|u fzj
700 1 _ |a Otto, Markus
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Dukart, Jürgen
|0 P:(DE-Juel1)177727
|b 3
|e Corresponding author
|u fzj
700 1 _ |a Schroeter, Matthias L.
|0 P:(DE-HGF)0
|b 4
|e Corresponding author
856 4 _ |u https://juser.fz-juelich.de/record/905420/files/Poster-1.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:905420
|p openaire
|p open_access
|p VDB
|p driver
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)177012
910 1 _ |a Institute of Systems Neuroscience, Heinrich Heine University Düsseldorf, Germany
|0 I:(DE-HGF)0
|b 0
|6 P:(DE-Juel1)177012
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)131678
910 1 _ |a Institute of Systems Neuroscience, Heinrich Heine University Düsseldorf, Germany
|0 I:(DE-HGF)0
|b 1
|6 P:(DE-Juel1)131678
910 1 _ |a Department of Neurology, Ulm University, Ulm, Baden Württemberg, Germany
|0 I:(DE-HGF)0
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)177727
910 1 _ |a Institute of Systems Neuroscience, Heinrich Heine University Düsseldorf, Germany
|0 I:(DE-HGF)0
|b 3
|6 P:(DE-Juel1)177727
910 1 _ |a Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences , Leipzig, Germany
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Clinic for Cognitive Neurology, University Hospital Leipzig, Germany
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2021
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
980 1 _ |a FullTexts
980 _ _ |a poster
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-7-20090406


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21